Abstract
Multiregion sequencing can advance our understanding of the intratumor heterogeneity and the clonal evolution. Here, we introduced multiple aspects of multiregion sequencing and its analysis, including the study design and sampling strategy, current understanding of the tumor evolution model, and a protocol for multiregion sequencing analysis of DNA-sequencing data.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Nowell PC (1976) The clonal evolution of tumor cell populations. Science 194(4260):23–28
Carter SL et al (2012) Absolute quantification of somatic DNA alterations in human cancer. Nat Biotechnol 30(5):413–421
Schwartz R, Schaffer AA (2017) The evolution of tumour phylogenetics: principles and practice. Nat Rev Genet 18(4):213–229
Jahn K et al (2016) Tree inference for single-cell data. Genome Biol 17:86
Tomlinson K, Oesper L (2019) Parameter, noise, and tree topology effects in tumor phylogeny inference. BMC Med Genomics 12(Suppl 10):184
Gerlinger M et al (2012) Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med 366(10):883–892
Gupta RG, Somer RA (2017) Intratumor heterogeneity: novel approaches for resolving genomic architecture and clonal evolution. Mol Cancer Res 15(9):1127–1137
Yan T et al (2019) Multi-region sequencing unveils novel actionable targets and spatial heterogeneity in esophageal squamous cell carcinoma. Nat Commun 10(1):1670
Ramazzotti D et al (2019) Learning mutational graphs of individual tumour evolution from single-cell and multi-region sequencing data. BMC Bioinformatics 20(1):210
Malikic S et al (2019) Integrative inference of subclonal tumour evolution from single-cell and bulk sequencing data. Nat Commun 10(1):2750
Shi W et al (2018) Reliability of whole-exome sequencing for assessing intratumor genetic heterogeneity. Cell Rep 25(6):1446–1457
McDonough SJ et al (2019) Use of FFPE-derived DNA in next generation sequencing: DNA extraction methods. PLoS One 14(4):e0211400
Jamal-Hanjani M et al (2017) Tracking the evolution of non-small-cell lung cancer. N Engl J Med 376(22):2109–2121
Van Allen EM et al (2014) Whole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicine. Nat Med 20(6):682–688
Zhang J et al (2014) Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing. Science 346(6206):256–259
Weaver JMJ et al (2014) Ordering of mutations in preinvasive disease stages of esophageal carcinogenesis. Nat Genet 46(8):837–843
Damm F et al (2014) Acquired initiating mutations in early hematopoietic cells of CLL patients. Cancer Discov 4(9):1088–1101
Yu Y et al (2019) Genome-wide copy number variation analysis identified ANO1 as a novel oncogene and prognostic biomarker in esophageal squamous cell cancer. Carcinogenesis 40(10):1198–1208
Rennstam K et al (2003) Patterns of chromosomal imbalances defines subgroups of breast cancer with distinct clinical features and prognosis. A study of 305 tumors by comparative genomic hybridization. Cancer Res 63(24):8861–8868
Han X et al (2019) Comprehensive profiling of gene copy number alterations predicts patient prognosis in resected stages I-III lung adenocarcinoma. Front Oncol 9:556
Luo F (2019) A systematic evaluation of copy number alterations detection methods on real SNP array and deep sequencing data. BMC Bioinformatics 20(Suppl 25):692
Hu Z, Curtis C (2016) Inferring tumor phylogenies from multi-region sequencing. Cell Syst 3(1):12–14
Beerenwinkel N et al (2015) Cancer evolution: mathematical models and computational inference. Syst Biol 64(1):e1–e25
Niida A et al (2018) Understanding intratumor heterogeneity by combining genome analysis and mathematical modeling. Cancer Sci 109(4):884–892
Davis A et al (2017) Tumor evolution: linear, branching, neutral or punctuated? Biochim Biophys Acta Rev Cancer 1867(2):151–161
Yates LR, Campbell PJ (2012) Evolution of the cancer genome. Nat Rev Genet 13(11):795–806
Sottoriva A et al (2015) A Big Bang model of human colorectal tumor growth. Nat Genet 47(3):209–216
Ling S et al (2015) Extremely high genetic diversity in a single tumor points to prevalence of non-Darwinian cell evolution. Proc Natl Acad Sci U S A 112(47):E6496–E6505
Williams MJ et al (2016) Identification of neutral tumor evolution across cancer types. Nat Genet 48(3):238–244
Fittall MW, Van Loo P (2019) Translating insights into tumor evolution to clinical practice: promises and challenges. Genome Med 11(1):20
Lindstrom HJG et al (2019) Stochastic modelling of tyrosine kinase inhibitor rotation therapy in chronic myeloid leukaemia. BMC Cancer 19(1):508
Landau DA et al (2013) Evolution and impact of subclonal mutations in chronic lymphocytic leukemia. Cell 152(4):714–726
Papaemmanuil E et al (2013) Clinical and biological implications of driver mutations in myelodysplastic syndromes. Blood 122(22):3616–3627; quiz 3699
Alves JM et al (2017) Multiregional tumor trees are not phylogenies. Trends Cancer 3(8):546–550
DiNardo Z et al (2019) Distance measures for tumor evolutionary trees. Bioinformatics
Roth A et al (2014) PyClone: statistical inference of clonal population structure in cancer. Nat Methods 11(4):396–398
Zare H et al (2014) Inferring clonal composition from multiple sections of a breast cancer. PLoS Comput Biol 10(7):e1003703
Popic V et al (2015) Fast and scalable inference of multi-sample cancer lineages. Genome Biol 16:91
Malikic S et al (2015) Clonality inference in multiple tumor samples using phylogeny. Bioinformatics 31(9):1349–1356
Dang HX et al (2017) ClonEvol: clonal ordering and visualization in cancer sequencing. Ann Oncol 28(12):3076–3082
Dentro SC et al (2017) Principles of reconstructing the subclonal architecture of cancers. Cold Spring Harb Perspect Med 7(8)
McGranahan N et al (2015) Clonal status of actionable driver events and the timing of mutational processes in cancer evolution. Sci Transl Med 7(283):283ra254
Harismendy O et al (2011) Detection of low prevalence somatic mutations in solid tumors with ultra-deep targeted sequencing. Genome Biol 12(12):R124
Acknowledgments
This work was partially supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (grant NRF-2015R1D1A1A02061597).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Ahn, S., Huang, H. (2021). Multiregion Sequence Analysis to Predict Intratumor Heterogeneity and Clonal Evolution. In: Shomron, N. (eds) Deep Sequencing Data Analysis. Methods in Molecular Biology, vol 2243. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-1103-6_14
Download citation
DOI: https://doi.org/10.1007/978-1-0716-1103-6_14
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-1102-9
Online ISBN: 978-1-0716-1103-6
eBook Packages: Springer Protocols